Krystal Biotech Inc at Bank of America Healthcare Conference Transcript
Hello. Good morning. Welcome to Day 1 of the 2022 Bank of America Healthcare Conference, and thank you for joining this session with Krystal Biotech. My name is Alec Stranahan. I'm Vice President and Senior Biotech Analyst covering Krystal here at BofA. And I'm pleased to be joined by Krish Krishnan, Chairman and CEO of Krystal. Thanks for joining us, Krish.
Thanks for having me.
Questions & Answers
Yes, so maybe we can just jump into the Q&A. And maybe we can just start off at a high level. Your redoseable gene therapy platform is pretty unique, right? And I think you've shown across multiple diseases that you can redose in sort of a sustainable way. So could you just sort of walk us through the technology and sort of where the company stands today?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
